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Coronary artery, aortic wall, and valvular calcification in non- Calcification of the blood vessels and cardiac valves
dialyzed individuals with type 2 diabetes and renal disease. has been recognized for over 100 years. The introduction
Background. Individuals with end-stage renal disease (ESRD) of electron beam computed tomography (CT) has refo-have highly prevalent and severe vascular and valvular calcifi-
cused attention on this complication of renal failure.cation. We undertook this study to test the hypothesis that
vascular and valvular calcification begins and is often severe Electron beam CT is noninvasive and highly sensitive in
long before diabetic renal disease progresses to ESRD. detecting calcification and hence is a valuable tool for
Methods. A total of 32 nondialyzed individuals with type 2 population-based studies to measure vascular (coronarydiabetes mellitus and diabetic renal disease (albumin excretion
artery and aortic wall) and valvular (aortic and mitral)rate30g/min) [mean glomerular filtration rate (GFR), 49.8
6.1 mL/min/1.73 m2] were identified and compared with a group calcification [1–3].
of 18 normoalbuminuric diabetics. We used 3:1 matching to iden- Recent studies using electron beam CT have found a
tify 95 nondiabetic controls without renal disease, matched for high prevalence and severity of coronary artery calcifica-
age, gender, ethnicity, and the presence/absence of dyslipid-
tion in patients with end-stage renal disease (ESRD)emia, hypertension, and known coronary artery disease (CAD).
[4–10]. This is concerning, since in the general populationResults. Using electron beam computed tomography (CT),
the prevalence of coronary artery calcification was significantly coronary artery calcification detected by electron beam
greater among diabetic renal disease individuals (prevalence, CT correlates strongly with atherosclerotic plaque bur-
94% vs. 59%, P  0.001; median score, 238 vs. 10, P  0.001)
den and the coronary artery calcification score predictsthan the nondiabetic controls. The coronary artery calcification
future fatal/nonfatal cardiovascular events [11]. It is pos-scores were significantly more severe among diabetic renal
disease individuals than either the diabetic or nondiabetic con- sible that the increased coronary artery calcification con-
trols. Among individuals with diabetic renal disease, the coro- tributes to the high cardiovascular morbidity and mortal-
nary artery calcification and aortic wall calcification scores were
ity in patients with ESRD, since a history of myocardialseveral-fold greater among those with known CAD than among
infarction or angina is associated with higher coronarythose without. There was also a significantly greater prevalence
of aortic and mitral valve calcification among diabetic renal artery calcification scores in these patients [8, 9]. While
disease individuals than nondiabetic controls (aortic, 23% vs. there has been some correlation between the traditional
6%, P  0.03; mitral, 25% vs. 2%, P  0.001). Multivariate risk factors for cardiovascular disease and coronary ar-analysis using all three groups reproduced these findings and
tery calcification in these studies, several investigatorsalso consistently identified age and diabetic renal disease as
additional predictors for the presence or severity of coronary have also demonstrated a correlation between coronary
artery and aortic wall calcification. artery calcification and serum phosphorus, calcium-phos-
Conclusion. In this first, systematic analysis among nondia- phorus product, serum intact parathyroid hormone, uselyzed individuals with diabetic renal disease, these data demon-
of calcium-based phosphate binders, and markers of in-strate that vascular and valvular calcification is present and
flammation [5, 8–10]. Thus, in individuals with ESRD,often severe long before the disease progresses to ESRD. The
data also suggest that the coronary artery and aortic wall calci- there are questions regarding the pathophysiology of the
fication may represent atherosclerosis. increased coronary artery calcification, the relationship
of the coronary artery calcification score with plaque
burden, and the prognostic value of a given coronaryKey words: diabetes mellitus, renal disease, calcification, coronary ar-
tery, aortic valve, mitral valve. artery calcification score. It is also unclear at what stage
of renal disease coronary artery calcification first begins
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microalbuminuria or proteinuria in diabetics, no system- sclerosis (FSGS) on renal biopsy, and three had discor-
dant results from two sets of urine protein data collectedatic study of this issue has been performed [12–16].
These recent studies in ESRD patients have also found close together in time. Of the remaining 40 patients, 32
were classified as having diabetic renal disease and eighta high prevalence of valvular calcification [4, 8, 9]. This
is also concerning since valvular calcification, even in the as having normoalbuminuria (diabetic controls, see below).
The data on the following four groups of patients areabsence of significant stenosis, is associated with increased
morbidity and mortality [17, 18]. Several echocardio- presented as follows: (1) diabetic renal disease, obtained
from a review of the electron beam CT database (N graphic studies in individuals with ESRD have demon-
strated strong correlations of valvular calcification with 32) [estimated glomerular filtration rate (GFR), 49.8 
6.1 mL/min/1.73 m2]; (2) diabetic controls, obtained fromaltered calcium and phosphorous metabolism [19–22].
Little is known about the magnitude of the problem and a review of electron beam CT database (N  8) (mean
GFR, 86.4  9.9 mL/min/1.73 m2) up until June 2001;its correlates in nondialyzed patients with renal disease.
This study was undertaken to evaluate coronary ar- (3) diabetic controls, studied as a part of an ongoing
prospective study (N  10) (mean GFR, 111.2  13.8tery, aortic wall, and valvular calcification in nondialyzed
individuals with diabetic renal disease. This is an appeal- mL/min/1.73 m2) and whose data were entered into the
electron beam CT database during the period June 2001ing group to study, because their calcification scores are
less likely to be influenced by the alterations in calcium to June 2002; and (4) nondiabetic controls, without renal
disease (N  95). The nondiabetic controls were identi-and phosphorous metabolism and medication regimens
characteristic of ESRD patients. The prevalence and se- fied from the electron beam CT database, using 3:1
matching with individuals with diabetic renal disease.verity of calcification in subjects with diabetic renal disease
were compared to normoalbuminuric diabetics and a The following parameters were matched to identify con-
trols: age, gender, ethnicity, and the presence/absence ofmatched group of nondiabetic controls without renal
disease. dyslipidemia, hypertension, and known coronary artery
disease (CAD).
Medical records were reviewed to determine ethnicity,
METHODS
traditional risk factors for cardiovascular disease (age, gen-
Patient selection and data collection der, dyslipidemia, hypertension, current tobacco use, obe-
sity, family history of premature CAD, and menopauseThis is a cross-sectional, case-control study of vascular
and valvular calcification in individuals with type 2 diabe- status), history of known CAD (myocardial infarction,
angina, positive stress test, angiographic evidence of CAD,tes mellitus and diabetic renal disease. Diabetic renal
disease was defined by the presence of proteinuria or albu- and history of myocardial revascularization), diabetes-
related factors [duration of diabetes mellitus and glyco-minuria, without the need for dialysis, and individuals were
included if they met at least one of the following criteria: sylated hemoglobin (HbA1C)], and renal-specific factors
[serum creatinine, blood urea nitrogen (BUN), serumurine protein 150 mg/day, urine albumin 30 g/min
or 30 mg/day, spot protein/creatinine ratio 0.15 or albumin, 24-hour urine protein excretion and GFR]. The
GFR was calculated using the regression equation de-spot albumin/creatinine ratio 0.03. Normoalbuminuria
was defined as urine albumin 30 g/min or 30 mg/ rived from the Modification of Diet in Renal Disease
study [23].day, or spot albumin/creatinine ratio0.03. The protocol
was reviewed and approved by the Institutional Review
Electron beam CTBoard of the Research and Education Institute at Har-
bor-UCLA Medical Center (HUMC). Electron beam CT studies were performed with a C-150
XL Ultrafast computed tomographic scanner (Imatron,The data for all individuals who are referred for electron
beam CT scanning at St. John’s Cardiovascular Research South San Francisco, CA, USA). The protocol used for
data acquisition has been described previously [24]. TheCenter at HUMC have been entered into a computerized
database. Data on risk factors for cardiovascular disease, scans of all individuals were retrieved, and the vascular
and valvular calcification was scored by a single, highlyincluding a history of diabetes mellitus, are available
for all individuals who have undergone scanning since experienced technician, using both the Agatston as well
as volumetric method [25, 26].January 1998. This database was reviewed to identify
diabetic individuals who had undergone scanning be-
Statistical analysistween January 1998 and June 2001, had received medical
care at HUMC, and had a urine protein measurement To test for statistically significant differences in the
prevalence of vascular and valvular calcification betweenproximate to the time of the electron beam CT scan. Of
the 51 individuals thus identified, 11 individuals were various groups or subgroups, chi-square or Fisher’s exact
test were used, as appropriate. As the number of diabeticexcluded for the following reasons: seven were undergo-
ing dialysis therapy, one had focal segmental glomerulo- controls were small, subgroup analyses was restricted to
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Table 1. Characteristics of individuals in the three study cohortsindividuals with diabetic renal disease and nondiabetic
controls. For us to include any risk factor for analyses, Diabetic Diabetic Nondiabetic
renal disease controls controlswe required that information for that risk factor be avail-
Number 32 18 95able on at least 75% of the subjects. Data on the follow-
Age years 571.5 58.21.9 570.9ing risk factors were obtained on75% of diabetic renal
Gender male/female 13/19 11/7 39/56
disease individuals: current tobacco use, obesity, family Ethnicity
Hispanic 20 (62%) 12 (67%) 59 (62%)history of premature CAD, and menopausal status. Thus,
African American 8 (25%) 2 (11%) 24 (25%)no analyses were performed using these risk factors. Con-
Caucasian 2 (6%) 4 (22%) 6 (6%)
tinuous variables are expressed either as the mean  Asian 2 (6%) 0 6 (6%)
Dyslipidemia 24 (75%) 15a (88%) 73 (77%)standard error of the mean (SEM) or as median and inter-
Hypertension 28b (90%) 10 (56%) 70 (74%)quartile range, as appropriate. To test whether there were
Known coronary
significant differences between two groups, t tests were artery disease 15 (47%) 6 (33%) 57 (60%)
used for normally distributed variables and the Mann- aN  17; bN  31
Whitney rank sum test was used for nonnormally distrib-
uted variables. As the calcification scores were right-
skewed, they were log transformed for further analyses.
To determine the significance of differences in calcifica- (Table 1). However, the individuals with diabetic renal
disease had significantly higher prevalence of hyperten-tion scores in more than two groups, analysis of variance
(ANOVA) was used. Pearson correlation coefficients sion (90% vs. 56%, P  0.01; Table 1). The mean dura-
tion of diabetes mellitus for the 32 diabetic renal diseasewere computed to test the association between continuous
variables and calcification scores. Multivariate analyses individuals at the time of electron beam CT was 12.7 
1.1 years, the last measured HbA1C was 7.9%  0.3%,were performed by combining all three groups: diabetic
renal disease patients, diabetic controls, and nondiabetic the serum creatinine proximate to the time of electron
beam CT was 2.0  0.3 mg/dL, and the GFR was 49.8 controls. Multivariate linear models were used to test
the combined effects of the presence of diabetic renal 6.1 mL/min/1.73 m2. The average serum albumin was
3.3 0.1 g/dL and the mean 24-hour urine protein excre-disease, age, gender, dyslipidemia, hypertension, and
known CAD on the calcification scores at each of the tion was 4.7  0.8 g/day. The diabetic controls had a
mean duration of diabetes mellitus of 10.1  1.6 years,four sites (coronary artery, aortic wall, aortic valve, and
mitral valve). Analysis of covariance (ANCOVA) was the last measured HbA1C was 8.7%  0.5% (N  13),
an average serum creatinine of 0.9  0.3 mg/dL, and aused when the outcome was the log-transformed raw
score. When the outcome was expressed as prevalence, GFR of 101.9  9.6 mL/min/1.73 m2.
The 32 diabetic renal disease individuals and 95 con-a logistic regression model was used. In these models,
dummy variables were used to represent diabetic and trols were well matched for age, gender, ethnicity, and
presence/absence of dyslipidemia (Table 1). There wasnondiabetic controls, so that each was compared to dia-
betic renal disease. Colinearities in the independent vari- a statistically nonsignificant trend toward a higher preva-
lence of hypertension (90% vs. 74%, P  0.09) and aables prevented us from obtaining reliable results in the
logistic models for the prevalence of aortic and mitral lower prevalence of known CAD (47% vs. 60%, P 
0.22) in diabetic renal disease individuals compared tovalve calcification. A P value 0.05 was considered sig-
nificant. controls.
Correlation between Agatston and volumetric method
RESULTS
The coronary artery, aortic wall, and aortic and mitral
Patient demographics valve calcification scores were calculated for each indi-
vidual using both the Agatston and the volumetricThere were no differences in the age, gender distribu-
tion, prevalence of hypertension or dyslipidemia or method. The two values for each of the four sites were
highly correlated (r  0.99, P  0.001 for each), andknown CAD or either the severity or prevalence of calci-
fication at any of the vascular or valvular sites between since past literature has primarily used the Agatston
method, all statistical analyses were performed using thethe two groups of diabetic controls. They did differ on
duration of diabetes (4.6  1.7 vs. 14.5  1.6 years, P  Agatston scores.
0.008). Therefore, the two groups were combined for all
Coronary artery calcificationanalyses and duration of diabetes was used as a covariate
in comparisons between this group and the group with Coronary artery calcification was present in 94% of
diabetic renal disease individuals, compared to all thediabetic renal disease. The diabetic control population
did not differ from the diabetic renal disease subjects on diabetic controls and 59% of nondiabetic controls (P 
0.001, compared to diabetic renal disease) (Table 2, Fig.age, gender, prevalence of dyslipidemia, or known CAD
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Table 2. Subgroup analyses of the prevalence and severity of coronary artery calcification in individuals with diabetic renal disease and
nondiabetic controls
Prevalence, % patients Severity, median score
Diabetic Nondiabetic Diabetic Nondiabetic
renal disease controls renal disease controls
Overall 94%a (N  32) 59% (N  95) 238a (55–789) 10 (0–90)
Gender
Male 92% (N  13) 67% (N  39) 619b (82–972) 18 (0–168)
Female 95%b (N  19) 54% (N  56) 232a (52–470) 6 (0–61)
Dyslipidemia
Present 92%b (N  24) 55% (N  73) 224a (49–789) 6 (0–89)
Absent 100% (N  8) 73% (N  22) 506b (171–679) 27 (0–111)
Hypertension
Present 96%b (N  28) 67%d (N  70) 238a (64–789) 17d (0–155)
Absent 67% (N  3) 36% (N  25) 4 (2–470) 0 (0–18)
Known coronary artery disease
Present 100%b (N  15) 60% (N  57) 543a,c (232–894) 16 (0–93)
Absent 88% (N  17) 58% (N  38) 74b (14–257) 7 (0–97)
The numbers in parentheses associated with the coronary artery calcification scores are the interquartile ranges in each designated subgroup.
aP  0.001 for difference between diabetic renal disease individuals and controls; bP  0.05 for difference between diabetic renal disease individuals and controls
cP  0.004 for difference between diabetic renal disease individuals with and without known coronary artery disease
dP  0.01 for difference between controls with and without hypertension
Fig. 2. The range of coronary artery calcification scores in diabetic
renal disease individuals, diabetic controls, and nondiabetic controls.
There was a significant difference in the range of distribution of coronary
artery calcification scores between individuals with diabetic renal disease
Fig. 1. The prevalence of coronary artery, aortic wall, aortic valve and and nondiabetic controls (P  0.001). Severe calcification (score 400)
mitral valve calcification in individuals with diabetic renal disease (N  was present in 41% of individuals with diabetic renal disease compared
32), diabetic controls (N  18) and in nondiabetic controls (N  95). to 11% of diabetic controls (P  0.06) and 9% of nondiabetic controls
Compared to diabetic controls, individuals with diabetic renal disease (P  0.001).
had a significantly greater prevalence of aortic wall calcification (66%
vs. 22%, P  0.008). Compared to nondiabetic controls, individuals with
diabetic renal disease had a significantly greater prevalence of coronary
artery calcification (94% vs. 59%, P  0.001), aortic wall calcification in Figure 2. Severe calcification (coronary artery calcifi-
(66% vs. 35%, P  0.004), aortic valve calcification (23% vs. 6%, P 
cation score 400) was present in 41% of diabetic renal0.02), and mitral valve calcification (25% vs. 2%, P  0.001).
disease individuals, compared to 11% of diabetic con-
trols (P  0.06, compared to diabetic renal disease) and
9% of nondiabetic controls (P  0.001, compared to
1). The results of the subgroup comparisons of preva- diabetic renal disease). The median coronary artery cal-
lence of coronary artery calcification between diabetic cification score in diabetic renal disease individuals was
renal disease individuals and nondiabetic controls are 2.5-fold greater than in diabetic controls [238 (55 to 789)
summarized in Table 2. The range of ccoronary artery vs. 96 (12 to 202), P  0.0001] and 24-fold greater than
calcification scores in individuals with diabetic renal dis- in nondiabetic controls [238 (55 to 789) vs. 10 (0 to 90),
P  0.001) (Table 2, Fig. 3).ease, diabetics, and nondiabetic controls are presented
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Fig. 4. Box and whisker plots for the coronary artery and aortic wall
calcification scores in diabetic renal disease individuals with (N  15)
Fig. 3. The median coronary artery and aortic wall calcification scores and without known coronary artery disease (CAD) (N  17). The hori-
in diabetic renal disease individuals (DRD) (N  32), diabetic controls zontal lines (from top to bottom) represent the maximum, 90th, 75th,
(N  18) and in nondiabetic controls (N  95). The horizontal lines 50th, 25th, and 10th percentiles. The median coronary artery calcifica-
(from top to bottom) represent the 75th and 25th percentile for the tion scores were significantly greater in individuals with known CAD
scores in individuals with diabetic renal disease and among controls. The compared to those without [543 (232 to 894) vs. 74 (14 to 257), P 
median coronary artery calcification scores were significantly greater in 0.004]. The aortic wall calcification scores were significantly greater in
individuals with diabetic renal disease than among diabetic controls individuals with known CAD compared to those without [427 (155 to
[238 (55 to 789) vs. 96 (12 to 202), P  0.0001] or nondiabetic controls 829) vs. 0 (0 to 88), P  0.003].
[238 (55 to 789) vs. 10 (0 to 90), P  0.001]. Similarly, the aortic wall
calcification scores were significantly greater in individuals with diabetic
renal disease than among nondiabetic controls [127 (0 to 520) vs. 0 (0
to 42), P  0.001]. The median aortic wall calcification score, as well
as the interquartile range among diabetic controls was 0 and was signifi- cantly higher prevalence of coronary artery calcification
cantly lower than among individuals with diabetic renal disease (P  (67% vs. 36%, P  0.01) and median coronary artery0.004). Thus, these data are not presented in the figure.
calcification score (17 (0 to155) vs. 0 (0 to18), P 0.005)
in individuals with hypertension compared to those with-
out hypertension (Table 2). There was also a significant
There was no significant difference in prevalence of correlation between age and coronary artery calcification
coronary artery calcification in various subgroups of dia- score (r 0.39, P 0.001). However, there was no signifi-
betic renal disease individuals (Table 2). In addition,
cant difference in coronary artery calcification prevalence
there was no significant difference or correlation be-
based upon gender, dyslipidemia or known CAD, and no
tween the coronary artery calcification scores in diabetic
significant difference in coronary artery calcification scorerenal disease individuals based on ethnicity, traditional
based upon ethnicity, gender, dyslipidemia or known CADrisk factors for cardiovascular disease (Table 2), diabe-
(Table 2).tes-related factors (duration of diabetes mellitus and
Using multivariate linear models to study all the sub-HbA1C), and renal-specific factors (serum creatinine,
jects together (diabetic renal disease and diabetic as wellBUN, serum albumin, 24-hour urine protein excretion,
as nondiabetic controls), increasing age, and the presenceor GFR). There was a trend toward a longer duration
of diabetic renal disease were significant, independentof diabetes mellitus among individuals with GFR  30,
predictors for the presence of coronary artery calcifica-when compared to those with GFR  30 (15.2  1.9
tion. In the ANCOVA model, in addition to age and theyears vs. 11.4  1.4 years); however, this difference did
presence of diabetic renal disease, male gender and thenot reach statistical significance (P 0.10). No significant
presence of hypertension were all independent predictorsdifferences were noted in the coronary artery calcifica-
of a greater severity of coronary artery calcification.tion scores among diabetic renal disease individuals with
GFR  30 [median, 216 (14 to 758), N  11] and  30
Aortic wall calcification[median, 250 (72 to 845), N  20] (P  0.45). However,
Aortic wall calcification was present in 66% of diabeticthe median coronary artery calcification score among
renal disease individuals, compared to 22% of diabeticdiabetic renal disease individuals with known CAD was
controls (P  0.008) and 35% of nondiabetic controlssignificantly greater than among diabetic renal disease
(P  0.004) (Fig. 1). Subgroup comparisons betweenindividuals without known CAD [543 (232 to 894) vs.
diabetic renal disease individuals and nondiabetic con-74 (14 to 257), P  0.004] (Table 2, Fig. 4).
Among the nondiabetic controls, there was a signifi- trols revealed a significantly higher prevalence of calcifi-
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cation in diabetic renal disease individuals that were compared to female nondiabetic controls. There was no
female, with or without dyslipidemia, hypertensive, or significant difference in prevalence of mitral valve calci-
with known CAD, compared to the corresponding sub- fication in the various subgroups of diabetic renal disease
group of nondiabetic controls. The median aortic wall individuals or nondiabetic controls.
calcification score in diabetic renal disease individuals Diabetic renal disease individuals with aortic valve
was greater than that in diabetic [median scores, 127 (0 calcification had a significantly greater BUN (52  9
to 520) vs. 0 (0 to 0), P  0.004] as well as nondiabetic mg/dL vs. 32  4 mg/dL, P  0.02) and duration of
controls [127 (0 to 520) vs. 0 (0 to 42), P  0.001] (Fig. diabetes mellitus (18 3 years vs. 11 1 years, P 0.02)
3). Subgroup comparisons between diabetic renal disease compared to diabetic renal disease individuals without
individuals and nondiabetic controls revealed a signifi- calcification. However, there were no other significant
cantly higher median calcification score in diabetic renal relationships between the presence or absence of aortic
disease individuals that were Hispanic, male or female, valve calcification and traditional, diabetes-related or re-
with or without dyslipidemia, or with hypertension or nal-specific factors, or coronary artery calcification, aor-
known CAD compared to the corresponding subgroup tic wall calcification, or mitral valve calcification. There
of nondiabetic controls. were no significant relationships between the presence
Among individuals with diabetic renal disease, there or absence of mitral valve calcification and any of the
was a significantly greater prevalence (87% vs. 47%, P  above factors in the diabetic renal disease individuals.
0.05) and median aortic wall calcification score [427 (155 As indicated above, the presence of colinearities in
to 829) vs. 0 (0 to 88), P  0.003] (Fig. 4) among those the independent variables prevented us from obtaining
with known CAD compared to those without known reliable results in the logistic models for the prevalence
CAD. In addition, there was a significant correlation of aortic and mitral valve calcification. Using ANCOVA,
between age and the calcification score (r  0.45, P  increasing age and the presence of diabetic renal disease
0.01). Among nondiabetic controls, there was no signifi- were significant predictors for the presence of aortic
cant difference in the prevalence of aortic wall calcifica- valve calcification. The presence of diabetic renal disease
tion in the various subgroups, but there was a significant
was the only significant, independent predictor for the
correlation between age and the calcification score (r 
presence of mitral valve calcification.0.40, P  0.001).
Using multivariate linear models, increasing age and
the presence of diabetic renal disease were the only sig- DISCUSSION
nificant predictors of the prevalence and severity of aor- In this first systematic analysis, we report a near-uni-
tic wall calcification. versal prevalence of coronary artery calcification among
both nondialyzed individuals with diabetic renal diseaseValvular calcification
as well as normoalbuminuric diabetics. Coronary artery
A total of 44% of individuals with diabetic renal dis-
calcification and aortic wall calcification were signifi-
ease had calcification of at least one of the two valves.
cantly more severe in the diabetic renal disease individu-Aortic and mitral valve calcification were, respectively,
als compared to both the diabetic and the nondiabeticpresent in 23% and 25% of diabetic renal disease individ-
controls without renal disease. Finally, aortic and mitraluals, compared to 11% and 11% of diabetic controls (P
valve calcification was highly prevalent among nondia-NS for both) and 6% and 2% of nondiabetic controls
lyzed individuals with diabetic renal disease.(P 0.02 and P 0.001, respectively) (Fig. 1). Subgroup
Several recent studies have addressed the issue of cor-comparisons between diabetic renal disease and nondia-
onary artery calcification in individuals with ESRD [4–9].betic control individuals revealed a significantly higher
The 94% prevalence of coronary artery calcification inprevalence of aortic valve calcification in diabetic renal
our diabetic renal disease individuals is similar to thedisease individuals who were female, hypertensive, or with
prevalence of 83% to 92% recently reported in adultsknown CAD compared to the corresponding subgroup
with ESRD [5, 8, 9]. This high prevalence of coronaryof nondiabetic controls. There was a significantly higher
artery calcification in our diabetic renal disease individualsprevalence of mitral valve calcification in individuals with
indicates that coronary artery calcification in diabeticsdiabetic renal disease who were male or female, with or
with renal disease begins long before they reach ESRD.without dyslipidemia or known CAD, or hypertensive
Our data do suggest that in most individuals with diabeticcompared to the corresponding subgroup of nondiabetic
renal disease, the coronary artery calcification scores arecontrols.
not as high as those reported in individuals with ESRDThere was no significant difference in the prevalence
[4, 7–9]. Nevertheless, 41% of the diabetic renal diseaseof aortic valve calcification in the various subgroups of
individuals had severe coronary artery calcification (scorediabetic renal disease individuals, but there was a signifi-
cantly greater prevalence in male nondiabetic controls 400), a score that is associated with a significantly
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higher risk for adverse cardiovascular events in the gen- in GFR [38]. In this present analysis there was no signifi-
cant correlation between any measure of renal functioneral population.
Two concerns have been raised with respect to the and either the prevalence or severity of coronary artery
calcification, but the relatively small sample size maysignificance of coronary artery calcification in individuals
with ESRD. First, in the general population, coronary have limited our ability to demonstrate a significant rela-
tionship. None of the individuals with diabetic renal dis-artery calcification scores represent a quantitative esti-
mate of the total atherosclerotic plaque burden, and ease in our study were treated with phosphate binders
or vitamin D or its analogs. Finally, recent studies havepredict adverse cardiovascular outcomes [11]. While the
calcification that occurs with atherosclerosis is localized highlighted the relationship between vascular calcifica-
tion in individuals with ESRD and markers of inflamma-to the intima of the blood vessels, individuals with diabe-
tes mellitus or those with advanced renal failure also tion [9, 39]. Data on markers of inflammation was not
available in this study and future studies need to evaluatedevelop medial calcification, unrelated to atherosclero-
sis. Although most studies of medial calcification in indi- the importance of this issue in nondialyzed individuals
with diabetic renal disease. Thus, it is likely that the rela-viduals with renal failure have examined arteries other
than the coronary arteries [27–30], early autopsy studies tive importance of various pathogenetic factors in vascular
calcification may differ at various stages of renal failure.suggested that medial calcification in the coronary arter-
ies was infrequent [31–34]. Subsequent publications, lim- This study also demonstrates a significantly higher
prevalence of valvular calcification in diabetic renal dis-ited to a few case reports, suggested that even when
medial calcification occurred in the coronaries, it repre- ease individuals compared to controls. The data on mitral
valve calcification are consistent with the early echocar-sented only a small fraction of the overall coronary calci-
fication burden [35, 36]. However, a systematic analysis diographic studies [20, 40]. Among individuals without
renal disease, vascular calcification is rare before the ageof the relative contribution of intimal and medial calcifi-
cation to the overall coronary calcification has not been of 60. Only 4% have aortic valve calcification and only
0.2% to1.1% have mitral valve calcification [41, 42]. Inperformed. Indeed, a recent analysis of coronary mor-
phology from individuals with ESRD reported greater the general population, the prevalence of both aortic
and mitral valve calcification increases progressively withatherosclerotic plaque calcification (intimal) and an in-
creased thickness of the media, when compared to indi- increasing age [42–45]. Indeed, the prevalence of aortic
valve calcification of 23% in our study population withviduals with normal renal function; however, no data on
the presence or severity of medial calcification were pre- a mean age of 57 years is similar to the 23% to 28%
prevalence reported among the elderly [42, 45]. Thesented [37]. In this study of diabetic renal disease individ-
uals, the only important predictor of the severity of coro- prevalence of 25% for mitral valve calcification in our
diabetic renal disease individuals is substantially greaternary artery calcification was the presence of known CAD.
These data are consistent with those reported by two than reported among the elderly in the general popula-
tion. Only 7% to 15% of individuals60 years of age haverecent studies in individuals with ESRD [8, 9] and sug-
gests that a significant proportion of coronary artery been reported to have mitral valve calcification [42, 43].
However, the prevalence of aortic and mitral valve calci-calcification may represent intimal calcification, associ-
ated with atherosclerotic plaque. Despite these consider- fication does not approach the levels reported in ESRD
populations using electron beam CT (aortic valve calci-ations, in the absence of histologic data, the precise con-
tribution of medial calcification to the overall coronary fication, 34% to 55%; and mitral valve calcification, 45%
to 59%) [4, 8]. Hence, like coronary artery calcification,artery calcification score cannot be defined.
Second, disturbances in divalent ion metabolism, ele- valvular calcification appears to begin early in the course
of progressive renal insufficiency in a significant propor-vated serum parathyroid hormone, the use of calcium-
based phosphate binders and chronic inflammation are tion of individuals with diabetic renal disease, long be-
fore ESRD.associated with the prevalence, severity and progression
of coronary artery calcification in ESRD individuals [5, Multiple studies in individuals without renal disease
have demonstrated correlations between valvular calci-8–10]. Although the vast majority of diabetic renal dis-
ease individuals had only mild to moderate renal insuffi- fication and the traditional risk factors for cardiovascular
disease and the presence of atherosclerotic disease atciency (GFR 49.8  6.1 mL/min/1.73 m2), it is possible
that these disturbances may contribute to the severity other sites, causing some authors to conclude that valvu-
lar calcification represents atherosclerosis [43, 45–50].of coronary artery calcification in nondialyzed diabetic
individuals with renal disease. When the GFR declines However, several echocardiographic studies in ESRD
patients have consistently demonstrated correlations be-below 70 mL/min/1.73 m2, serum parathyroid hormone
and phosphorus increase and serum calcium decreases tween valvular calcification and age, duration of dialysis,
serum phosphorous, calcium-phosphorous product, and[38]. Specifically, changes in serum levels of parathyroid
hormone and phosphorus are closely correlated to changes parathyroid hormone levels [19–22], as opposed to the
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traditional risk factors for cardiovascular disease. Finally, CONCLUSION
among individuals with ESRD, aortic valve calcification Nondialyzed individuals with diabetic renal disease
ascertained by electron beam CT correlated with coro- have a significantly greater prevalence and severity of
nary artery calcification in both the studies that have vascular and valvular calcification compared to matched
looked at this issue; mitral valve calcification correlated nondiabetic controls with normal renal function. Coro-
with coronary artery calcification in only one of the two nary and aortic wall calcification is significantly greater
among individuals with diabetic renal disease, when com-studies [4, 8]. In this study, other than a higher BUN
pared to normoalbuminuric diabetics. This demonstratesand longer duration of diabetes mellitus among individu-
that the severe calcification seen in subjects with ESRDals with aortic valve calcification, there were no other
actually begins long before renal insufficiency is severerelationships between the presence or absence of aortic
enough to require dialysis. The increased coronary arteryor mitral valve calcification and the traditional risk fac-
calcification and aortic wall calcification may representtors for cardiovascular disease, diabetes-related factors,
atherosclerosis; the significance of valvular calcificationrenal-specific factors, or coronary artery calcification or
needs to be defined in future studies.aortic wall calcification. Hence, future studies need to
focus on the pathophysiologic basis and significance of
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